Work

Patients with high-risk acute promyelocytic leukemia need maintenance therapy for 1 year - the PROS

Year: 2025

Type: article

Abstract: Not available.

Source: Haematologica

DOI: 10.3324/haematol.2025.287417

Author: Martin S. Tallman

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Retinoids in leukemia and cellular processes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,157

OpenAlex ID: W4409115193

FWCI:

Cites: 13

Cited by:

Related to: 10